HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

sovaSage Wins Sleep Solution Provider Award
The company’s services include sovaFit, sovaStart and sovaGuide, all to support sleep apnea patients.

April 17, 2026 by Laurie Watanabe

sovaSage has been named a Top 10 Sleep Therapy Solution Provider for 2026.

“This recognition underscores sovaSage’s role in transforming how sleep therapy is delivered, combining advanced analytics, behavioral science, and human-centered design to improve patient outcomes and operational efficiency across the care continuum,” the company said in an April 16 news announcement. The award was presented by Healthcare Business Outlook.

“At sovaSage, we believe better outcomes come from better insight and proactive response,” said William Kaigler, the company’s co-founder and CEO. “This recognition validates the work we are doing to help providers deliver more personalized care, reduce guesswork, and drive long-term adherence for patients with sleep apnea.”

sovaSage noted that as sleep care “evolves from device delivery to longitudinal patient management,” the company is dedicated to “helping providers, health systems and partners move beyond fragmented workflows toward a more connected, insight-driven model.”

The company’s services include sovaFit, which enables artificial intelligence-guided mask fitting for sleep apnea patients; sovaStart, which streamlines PAP setup by using structured, patient-centering onboarding; and sovaGuide, which delivers ongoing monitoring and coaching along with intervention insights.

The Top 10 Sleep Therapy Solution Providers for 2026 program evaluates companies for their innovation, clinical impact, operational value and ability to meet and address emerging health care delivery challenges.

Related Articles Read More >

NCPA Announces New Senior Vice President of the Office of CEO
Sara Roszak is an industry veteran who most recently served at the National Association of Chain Drug Stores.
More HCPCS Codes to Be Added to Medicare Prior Authorization Process in October
Prior authorization will be required for eight additional codes for dates of service of Oct. 28 and later.
M&A Update, Part 2: What Makes a Good Investment or Acquisition?
At the HME Business FUTURE conference, experts on mergers and acquisitions took the stage.
Frazier Healthcare Acquires MatrixCare, Appoints CEO
MatrixCare was owned by Resmed.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe